Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways

by Lu Zhou, Emanuela Ercolano, Sylwia Ammoun, M. Caroline Schmid, Magdalena A. Barczyk, Clemens Oliver Hanemann
Published 2011-12-01

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

by Caterina Negroni, David A. Hilton, Emanuela Ercolano, Claire L. Adams, Kathreena M. Kurian, Daniele Baiz, C.Oliver Hanemann
Published 2020-09-01

A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in <i>AKT1 E17K</i> Mutated Tumours

by Claire L. Adams, Emanuela Ercolano, Sara Ferluga, Agbolahan Sofela, Foram Dave, Caterina Negroni, Kathreena M. Kurian, David A. Hilton, C. Oliver Hanemann
Published 2020-02-01

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma

by Jade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, Mahindra Makhija, Allison Berger, Todd Sells, Steve Stroud, David Hilton, Claire L Adams, C Oliver Hanemann
Published 2020-06-01

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

by Agbolahan A Sofela, David A Hilton, Sylwia Ammoun, Daniele Baiz, Claire L Adams, Emanuela Ercolano, Michael D Jenkinson, Kathreena M Kurian, Mario Teo, Peter C Whitfield, Felix Sahm, C Oliver Hanemann
Published 2021-01-01